Tokyo (JCNN) - Olympus (TSE: 7733) announced on April 7 that it has entered into a technical collaboration with AntiCancer, a US biotechnology firm specialized in developing anticancer agents and diagnostics. From mid-April, the two companies will conduct joint research on small animal molecular imaging.
